Related references
Note: Only part of the references are listed.Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects
Yong-Chang Liu et al.
TUMOR BIOLOGY (2015)
Glioblastoma: From Molecular Pathology to Targeted Treatment
Timothy F. Cloughesy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
The Hippo signaling pathway in stem cell biology and cancer
Jung-Soon Mo et al.
EMBO REPORTS (2014)
Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
Ning Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Making new contacts: the mTOR network in metabolism and signalling crosstalk
Mitsugu Shimobayashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Overcoming resistance to rapalogs in gliomas by combinatory therapies
Michal Grzmil et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
mTOR in aging, metabolism, and cancer
Marion Cornu et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
Nutrient regulation of the mTOR Complex 1 signaling pathway
Sang Gyun Kim et al.
MOLECULES AND CELLS (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Protor-2 interacts with tristetraprolin to regulate mRNA stability during stress
Brent Holmes et al.
CELLULAR SIGNALLING (2012)
Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP
Eric Miller et al.
CHEMISTRY & BIOLOGY (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Emerging insights into the molecular and cellular basis of glioblastoma
Gavin P. Dunn et al.
GENES & DEVELOPMENT (2012)
Hippo-YAP and mTOR pathways collaborate to regulate organ size
Alfred Csibi et al.
NATURE CELL BIOLOGY (2012)
YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29
Karen Tumaneng et al.
NATURE CELL BIOLOGY (2012)
Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
K. Masui et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
A. Fernandez-L et al.
ONCOGENE (2012)
Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice
Tariq Bashir et al.
PLOS ONE (2012)
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Wanjin Hong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Wenqi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth
Brent A. Orr et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Murugan Paramasivam et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma
Cheri Cloninger et al.
MOLECULAR CANCER THERAPEUTICS (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
Peggy P. Hsu et al.
SCIENCE (2011)
Oncogenic EGFR Signaling Activates an mTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka et al.
CANCER DISCOVERY (2011)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
Deciphering Protein Kinase Specificity Through Large-Scale Analysis of Yeast Phosphorylation Site Motifs
Janine Mok et al.
SCIENCE SIGNALING (2010)
TOR complex 2: a signaling pathway of its own
Nadine Cybulski et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Merlin is apotent inhibitor of glioma growth
Ying-Ka Ingar Lau et al.
CANCER RESEARCH (2008)
Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling
Oak D. Jo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Meningioma Cell Growth by Signaling through YAP
Katherine Striedinger et al.
NEOPLASIA (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor
Janine Masri et al.
CANCER RESEARCH (2007)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
GATA6 is an astrocytoma tumor suppressor gene identified by gene trapping of mouse glioma model
Deepak Kamnasaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics
Piergiorgio Modena et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Share Paper
